FORXIGA 5MG 28TAB

FORXIGA 5MG 28TAB

Forxiga (dapagliflozin) is an SGLT‑2 inhibitor used primarily in Type 2 diabetes mellitus to help lower blood glucose by:

• Blocking glucose reabsorption in the kidneys,

• Increasing sugar excretion in urine,

• Also approved for chronic kidney disease and heart failure management

📌 Indications

• Type 2 diabetes (as monotherapy or add-on) .

• Heart failure with reduced ejection fraction

• Chronic kidney disease (with or without diabetes).

⚙️ Dosage & Administration

• Typical starting dose: 5 mg once daily in the morning, with or without food

• May increase to 10 mg daily based on tolerance and kidney function (eGFR ≥ 60 mL/min)

• In severe liver impairment, doctors may use 5 mg

⚠️ Warnings & Precautions

• Contraindicated if allergic to dapagliflozin or excipients

• Not for Type 1 diabetes or diabetic ketoacidosis

• Risk of Fournier’s gangrene (a rare, serious genital infection)—seek immediate care if symptoms like pain or swelling occur

• Use with caution in elderly patients, kidney impairment, low blood pressure, or those on diuretics

• Avoid if pregnant, breastfeeding, or galactose-intolerant